ARMC
BIVV

American Research & Management Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

American Research & Management Company’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,931
Closed -$697K – 381
2017
Q4 		$697K Sell
12,931
-30
-0.2% -$1.64K 0.22% 79
2017
Q3 		$740K Buy
12,961
+1,678
+15% +$98.3K 0.24% 74
2017
Q2 		$679K Buy
11,283
+3,992
+55% +$227K 0.22% 74
2017
Q1 		$397K Buy
+7,291
New +$359K 0.14% 83

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

American Research & Management Company's BIVV Position: Q1 2018 in Review

American Research & Management Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 12,931 shares — an estimated $697K sold.

American Research & Management Company first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $740K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • American Research & Management Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • American Research & Management Company sold 12,931 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $697K.
  • American Research & Management Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • American Research & Management Company's Bioverativ Inc. Common Stock position peaked at $740K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on American Research & Management Company's 13F filing for Q1 2018, filed 19 Apr 2018.